Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer.
Saved in:
| Title: | Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer. |
|---|---|
| Authors: | O'Reilly EM; Memorial Sloan Kettering Cancer Center, New York., Wainberg ZA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles., Hendifar AE; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles., Borad MJ; Department of Oncology, Mayo Clinic, Phoenix, AZ., Pietrantonio F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan., Pant S; M.D. Anderson Cancer Center, Houston., Hammel P; Hôpital Paul-Brousse, Assistance Publique-Hôpitaux de Paris, Université Paris-Saclay, Villejuif, France., Cremolini C; Azienda Ospedaliero-Universitaria Pisana and Università di Pisa, Pisa, Italy., Manji GA; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York., Oberstein PE; Department of Hematology-Oncology, NYU Langone Health, New York University, New York., Garrido-Laguna I; Huntsman Cancer Institute, University of Utah, Salt Lake City., Springfeld C; Heidelberg University Hospital, National Center for Tumor Diseases, Heidelberg, Germany., Azad NS; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore., Ueno M; Department of Gastroenterology, Kanagawa Cancer Center, Yokohama, Japan., Chui SY; Revolution Medicines, Redwood City, CA., Zhang Y; Revolution Medicines, Redwood City, CA., Patel H; Revolution Medicines, Redwood City, CA., Lee Y; Revolution Medicines, Redwood City, CA., Salman Z; Revolution Medicines, Redwood City, CA., Wolpin BM; Hale Family Center for Pancreatic Cancer Research, Dana-Farber Cancer Institute, Boston. |
| Corporate Authors: | RASolute 302 Trial Investigators |
| Source: | The New England journal of medicine [N Engl J Med] 2026 Jul 23; Vol. 395 (4), pp. 325-337. Date of Electronic Publication: 2026 May 31. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study; Comparative Study |
| Journal Info: | Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42223072 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22O'Reilly+EM%22">O'Reilly EM</searchLink>; Memorial Sloan Kettering Cancer Center, New York.<br /><searchLink fieldCode="AU" term="%22Wainberg+ZA%22">Wainberg ZA</searchLink>; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles.<br /><searchLink fieldCode="AU" term="%22Hendifar+AE%22">Hendifar AE</searchLink>; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles.<br /><searchLink fieldCode="AU" term="%22Borad+MJ%22">Borad MJ</searchLink>; Department of Oncology, Mayo Clinic, Phoenix, AZ.<br /><searchLink fieldCode="AU" term="%22Pietrantonio+F%22">Pietrantonio F</searchLink>; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan.<br /><searchLink fieldCode="AU" term="%22Pant+S%22">Pant S</searchLink>; M.D. Anderson Cancer Center, Houston.<br /><searchLink fieldCode="AU" term="%22Hammel+P%22">Hammel P</searchLink>; Hôpital Paul-Brousse, Assistance Publique-Hôpitaux de Paris, Université Paris-Saclay, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Cremolini+C%22">Cremolini C</searchLink>; Azienda Ospedaliero-Universitaria Pisana and Università di Pisa, Pisa, Italy.<br /><searchLink fieldCode="AU" term="%22Manji+GA%22">Manji GA</searchLink>; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York.<br /><searchLink fieldCode="AU" term="%22Oberstein+PE%22">Oberstein PE</searchLink>; Department of Hematology-Oncology, NYU Langone Health, New York University, New York.<br /><searchLink fieldCode="AU" term="%22Garrido-Laguna+I%22">Garrido-Laguna I</searchLink>; Huntsman Cancer Institute, University of Utah, Salt Lake City.<br /><searchLink fieldCode="AU" term="%22Springfeld+C%22">Springfeld C</searchLink>; Heidelberg University Hospital, National Center for Tumor Diseases, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Azad+NS%22">Azad NS</searchLink>; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore.<br /><searchLink fieldCode="AU" term="%22Ueno+M%22">Ueno M</searchLink>; Department of Gastroenterology, Kanagawa Cancer Center, Yokohama, Japan.<br /><searchLink fieldCode="AU" term="%22Chui+SY%22">Chui SY</searchLink>; Revolution Medicines, Redwood City, CA.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; Revolution Medicines, Redwood City, CA.<br /><searchLink fieldCode="AU" term="%22Patel+H%22">Patel H</searchLink>; Revolution Medicines, Redwood City, CA.<br /><searchLink fieldCode="AU" term="%22Lee+Y%22">Lee Y</searchLink>; Revolution Medicines, Redwood City, CA.<br /><searchLink fieldCode="AU" term="%22Salman+Z%22">Salman Z</searchLink>; Revolution Medicines, Redwood City, CA.<br /><searchLink fieldCode="AU" term="%22Wolpin+BM%22">Wolpin BM</searchLink>; Hale Family Center for Pancreatic Cancer Research, Dana-Farber Cancer Institute, Boston. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22RASolute+302+Trial+Investigators%22">RASolute 302 Trial Investigators</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220255562%22">The New England journal of medicine</searchLink> [N Engl J Med] 2026 Jul 23; Vol. 395 (4), pp. 325-337. <i>Date of Electronic Publication: </i>2026 May 31. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study; Comparative Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Massachusetts+Medical+Society%22">Massachusetts Medical Society </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0255562 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1533-4406 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200284793%22">00284793 </searchLink><i>NLM ISO Abbreviation: </i>N Engl J Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42223072 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1056/NEJMoa2605555 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 325 Titles: – TitleFull: Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: O'Reilly EM – PersonEntity: Name: NameFull: Wainberg ZA – PersonEntity: Name: NameFull: Hendifar AE – PersonEntity: Name: NameFull: Borad MJ – PersonEntity: Name: NameFull: Pietrantonio F – PersonEntity: Name: NameFull: Pant S – PersonEntity: Name: NameFull: Hammel P – PersonEntity: Name: NameFull: Cremolini C – PersonEntity: Name: NameFull: Manji GA – PersonEntity: Name: NameFull: Oberstein PE – PersonEntity: Name: NameFull: Garrido-Laguna I – PersonEntity: Name: NameFull: Springfeld C – PersonEntity: Name: NameFull: Azad NS – PersonEntity: Name: NameFull: Ueno M – PersonEntity: Name: NameFull: Chui SY – PersonEntity: Name: NameFull: Zhang Y – PersonEntity: Name: NameFull: Patel H – PersonEntity: Name: NameFull: Lee Y – PersonEntity: Name: NameFull: Salman Z – PersonEntity: Name: NameFull: Wolpin BM IsPartOfRelationships: – BibEntity: Dates: – D: 23 M: 07 Text: 2026 Jul 23 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1533-4406 Numbering: – Type: volume Value: 395 – Type: issue Value: 4 Titles: – TitleFull: The New England journal of medicine Type: main |
| ResultId | 1 |